Otros idiomas Zeria Pharmaceutical Co., Ltd.

Acciones

4559

JP3428850006

Mercado cerrado - Japan Exchange Otros sitios de cotización 08:00:00 13/05/2024			Varia. Cinco días.	Varia. 1 de enero.
2.039 ^JPY	+1,90 %		-2,67 %	+1,09 %

09/05	Zeria Pharmaceutical Co. Proporciona una Guía de Beneficios Consolidados para los Seis Primeros Meses y el Año Completo que Finaliza el 31 de Marzo de 2025	CI
23/04	Borsch Med Pte. Ltd. Introduce en Singapur los suplementos de condroitina de Zeria Pharmaceutical Co. Ltd en Singapur para unas articulaciones sanas	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Zeria Pharmaceutical Co., Ltd. Announces Year End Dividend for the Full Year Ending March 31, 2024, Payable on June 28, 2024	09/05
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Six Months and Full Year Ending March 31, 2025	09/05
Zeria Pharmaceutical Co., Ltd. Provides Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2025	09/05
Borsch Med Pte. Ltd. Introduces Chondroitin Supplements of Zeria Pharmaceutical Co. Ltd to Singapore for Healthy Joints	23/04
Zeria Pharmaceutical's Profit Up 41% in Fiscal Q1-Q3	16/02
Japanese Shares End Firmer on Friday on BoJ Policy Outlook	17/11
Zeria Pharmaceutical Books Higher Fiscal H1 Attributable Profit on Loss Provision Reversal	17/11
Zeria Pharmaceutical Co., Ltd. Announces Dividend for the Second Quarter of Fiscal Year Ending March 31, 2024, Payable on December 1, 2023	16/11
Zeria Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024	16/11
Zeria Pharmaceutical’s Attributable Profit Up 12.1% in Fiscal Q1 on Absence of Forex Losses	23/08/23
Zeria Pharmaceutical Co., Ltd. Provides Dividend Forecast for the Fiscal Year Ending March 31, 2024	22/08/23
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Financial Forecast for the Six Months of 2024 and the Fiscal Year Ending March 31, 2024	22/08/23
Zeria Pharmaceutical Co., Ltd. Provides Dividend Forecast for the Second Quarter of 2024	22/08/23
Zeria Pharmaceutical : 69th Business Report (From April 1, 2022 to March 31, 2023.)	25/07/23
Zeria Pharmaceutical : Notice of the 69th Ordinary Stockholders' General Assembly	26/05/23
Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.	16/05/23
Zeria Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 11, 2022, has closed with 263,900 shares, representing 0.6% for ¥545.29 million.	12/05/23
Zeria Pharmaceutical Co., Ltd. Provides Year End Dividend Guidance for the Full Year Ending March 31, 2024	11/05/23
Zeria Pharmaceutical Co., Ltd. Announces Year End Dividend for the Full Year Ending March 31, 2023, Payable on June 30, 2023; Provides Second Quarter Dividend Guidance for the Full Year Ending March 31, 2024	11/05/23
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Six Months and Full Year Ending March 31, 2024	11/05/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Zeria Pharmaceutical Co., Ltd.

Acciones

4559

JP3428850006

Otros idiomas

Filtros